These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 144010)

  • 1. [In vivo assay of antisomatotropic activity of somatostatin and two of its analogs].
    Franchimont P; Ghys A; Brison J; Haze-Hagelstein MT; Detournay JM; Dremier C; Scarso A; Demoulin A; Dirkx J
    C R Seances Soc Biol Fil; 1977; 171(3):673-8. PubMed ID: 144010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of highly potent heptapeptide analogs of somatostatin with C-terminal modifications.
    Janecka A; Zubrzycka M
    Endocr Regul; 2001 Jun; 35(2):75-9. PubMed ID: 11563935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.
    Murphy WA; Taylor JE; Moreau JP; Coy DH
    Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.
    Tran TA; Mattern RH; Afargan M; Amitay O; Ziv O; Morgan BA; Taylor JE; Hoyer D; Goodman M
    J Med Chem; 1998 Jul; 41(15):2679-85. PubMed ID: 9667958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity.
    Kéri G; Mezô I; Vadász Z; Horváth A; Idei M; Vántus T; Balogh A; Bökönyi G; Bajor T; Teplán I
    Pept Res; 1993; 6(5):281-8. PubMed ID: 7903057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies.
    Osapay G; Prokai L; Kim HS; Medzihradszky KF; Coy DH; Liapakis G; Reisine T; Melacini G; Zhu Q; Wang SH; Mattern RH; Goodman M
    J Med Chem; 1997 Jul; 40(14):2241-51. PubMed ID: 9216843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of anesthetic agents on the release of growth hormone induced by growth hormone-releasing hormone in rats.
    Hosoi E; Saito H; Yamasaki R; Kimura S; Saito S
    Tokushima J Exp Med; 1988 Dec; 35(3-4):85-90. PubMed ID: 2908215
    [No Abstract]   [Full Text] [Related]  

  • 8. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity.
    Teplán I
    Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrally applied somatostatin inhibits the estrogen-induced luteinizing hormone surge via hypothalamic gonadotropin-releasing hormone cell activation in female rats.
    Van Vugt HH; Swarts HJ; Van de Heijning BJ; Van der Beek EM
    Biol Reprod; 2004 Sep; 71(3):813-9. PubMed ID: 15140796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bicyclo-somatostatin analog, highly specific for the inhibition of growth hormone release.
    Sarantakis D; Teichman J; Clark DE; Lien EL
    Biochem Biophys Res Commun; 1977 Mar; 75(1):143-8. PubMed ID: 849303
    [No Abstract]   [Full Text] [Related]  

  • 14. Observations on the growth hormone, insulin, and glucagon release-inhibiting activities of somatostatin analogues.
    Coy DH; Meyers C; Arimura A; Schally AV; Redding TW
    Metabolism; 1978 Sep; 27(9 Suppl 1):1407-10. PubMed ID: 683009
    [No Abstract]   [Full Text] [Related]  

  • 15. Variability of the duration of inhibition of growth hormone release by Nalpha-acylated-des-(Ala1-Gly2)-H2somatostatin analogs.
    Brown M; Rivier J; Vale W; Guillemin R
    Biochem Biophys Res Commun; 1975 Jul; 65(2):752-6. PubMed ID: 807218
    [No Abstract]   [Full Text] [Related]  

  • 16. Octapeptide analogs of somatostatin exhibiting greatly enhanced in vivo and in vitro inhibition of growth hormone secretion in the rat.
    Murphy WA; Heiman ML; Lance VA; Mezo I; Coy DH
    Biochem Biophys Res Commun; 1985 Nov; 132(3):922-8. PubMed ID: 2866766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities of tyrosine-containing somatostatin analogs on inhibition of secretion of thyrotropin and growth hormone.
    Ohashi S; Sawano S; Kokubu T; Gondo M; Sakakibara K
    Endocrinol Jpn; 1976 Oct; 23(5):435-8. PubMed ID: 1009896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure activity studies on somatostatin.
    Sarantakis D; McKinley WA; Jaunakais I; Clark D; Grant NH
    Clin Endocrinol (Oxf); 1976; 5 Suppl():275S-278S. PubMed ID: 1052780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by six somatostatin analogs of plasma growth hormone levels stimulated by thiamylal and morphine in the rat.
    Ferland L; Labrie F; Coy DH; Arimura A; Schally AV
    Mol Cell Endocrinol; 1976 Jan; 4(2):79-88. PubMed ID: 1248667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel somatostatin analogs with tyrosine kinase inhibitory and antitumor activity.
    Kéri G; Mezö I; Horváth A; Vadász Z; Balogh A; Idei M; Vántus T; Teplán I; Mák M; Horváth J
    Biochem Biophys Res Commun; 1993 Mar; 191(2):681-7. PubMed ID: 8096383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.